Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.10525
Bid: 0.103
Ask: 0.1075
Change: 0.00 (0.00%)
Spread: 0.0045 (4.369%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.10525
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Superdry partners with Versarien

16 Nov 2021 12:31

RNS Number : 5619S
Versarien PLC
16 November 2021
 

Reach - Non-Regulatory

16 November 2021

Versarien plc

("Versarien" or the "Company")

Superdry pioneers production of enhanced garments with new partner Versarien

Versarien Plc (AIM:VRS), the advanced engineering materials group, is pleased to announce the public launch of the Company's commercial collaboration agreement with DKH Retail Limited, the worldwide wholesale distribution subsidiary of Superdry plc ("Superdry"). Superdry has announced today its partnership with Versarien to pioneer the production of graphene-enhanced garments, using Versarien's GRAPHENE-WEARTM technology, with a view to importing graphene's thermal and moisture management properties into its garments.

Superdry has stated that it believes using Versarien's innovative graphene technology will result in product lines with improved performance and extended product lifespan, with lower environmental impact in their creation, whilst also reducing the need to add any virgin material during recycling. Superdry believes having access to Versarien's scientists and laboratories in Manchester and Cambridge will accelerate the brand's innovation platform, enabling Superdry and Versarien to create garments unlike any others on the market.

The garments that are being developed will exploit the thermal regulatory properties of Versarien's GRAPHENE-WEARTM, creating a premium range of products adapted and designed to be highly technical and innovative. Control over thermal transmittance and regulation is intended to help the body manage its temperature, particularly in extreme climates and circumstances when the body is under stress. The strength of graphene is another area that is intended to improve the functionality of the garments, allowing for garments that will last longer with little fibre failure, increasing the number of wears and washes per garment, supporting Superdry's commitment to sustainability.

Commenting, Neill Ricketts, CEO of Versarien, said: "We are delighted that Superdry has publicly announced our collaboration. Since we started working with Superdry we have developed a number of sample garments and its decision to announce the collaboration and the future launch of the products we are developing together is, I believe, testament to the benefits they see in utilising Versarien's graphene technology. We look forward to continuing to work with Superdry to bring these innovative garment ranges to the market as soon as possible."

For further information please contact:

Versarien

Neill Ricketts, CEO

Chris Leigh, CFO

+44 (0) 1594 887204

 

SP Angel Corporate Finance (Nominated Adviser and Joint Broker)

Matthew Johnson, Ewan Leggat, Adam Cowl

+44 (0)20 3470 0470

Berenberg (Joint Broker)

Mark Whitmore, Ciaran Walsh

+44 (0)20 3207 7800

Yellow Jersey (Investor Relations) 

Charles Goodwin

Henry Wilkinson

Versarien@yellowjerseypr.com

+44 (0)20 3004 9512

 

Notes to Editors:

About Versarien

Versarien Plc (AIM: VRS), is an advanced engineering materials group. Leveraging proprietary technology, the Group creates innovative engineering solutions for its clients in a diverse range of industries.

For further information please see: http://www.versarien.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRALQLFFFFLLFBV
Date   Source Headline
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting
9th Jun 20237:00 amRNSInterim Results
31st May 20237:00 amRNSTotal Voting Rights
17th May 20237:00 amRNSSuccessful Cementene precast concrete trials
3rd May 20239:30 amRNSPlacing and Update on Turnaround Strategy
31st Mar 20237:00 amRNSTotal Voting Rights
29th Mar 202311:22 amRNSResult of AGM
29th Mar 20237:00 amRNSAGM Statement
15th Mar 20237:00 amRNSPlacing to raise £318,000
14th Mar 20232:56 pmRNSFurther re Resignation of Chief Executive Officer
10th Mar 20237:00 amRNSResignation of Chief Executive Officer
6th Mar 20237:00 amRNSCostain Civil Engineering Project
1st Mar 202312:00 pmRNSUmbro Launch
28th Feb 20237:00 amRNSNotice of AGM and Posting of Annual Report
21st Feb 20237:00 amRNSResults for the 18 months ended 30 September 2022
9th Feb 20238:33 amRNSAIM Rule 17 Update
27th Jan 20237:00 amRNSGraphene-Wear OEKO-TEX Eco Passport certification
24th Jan 20231:56 pmRNSFinal Results Update
30th Dec 20227:00 amRNSTotal Voting Rights
6th Dec 20229:40 amRNSPlacing to raise £1.85 million
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSG-SCALE Update & Innovate UK Loan Variation
2nd Dec 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.